Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Search Results (579)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Pancreatic cancer thromboembolic outcomes: rate of thrombosis after adenocarcinoma and non-adenocarcinoma pancreatic cancer surgery.Academic Article Why?
Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines.Academic Article Why?
Management Controversies and Treatment Strategies for Borderline Resectable Pancreatic Cancer.Academic Article Why?
Pancreatic cancer: an update.Academic Article Why?
25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).Academic Article Why?
A family history of pancreatic cancer.Academic Article Why?
A Glimmer of Hope for Pancreatic Cancer.Academic Article Why?
A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer.Academic Article Why?
A novel anti-pancreatic cancer agent, LY293111.Academic Article Why?
A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest.Academic Article Why?
A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer.Academic Article Why?
A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care.Academic Article Why?
A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk.Academic Article Why?
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.Academic Article Why?
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?Academic Article Why?
Per Page    Page  of 39last Nextnext
Prev
Search Criteria
  • Pancreatic Neoplasms
Filter by Type